Health ❯ Patient Care

Chronic Illness Management

Quality of Life Treatment Options Parkinson's Disease Innovative Treatments Pain Management Diabetes Management Support for Families ME/CFS Treatment Support Systems Kidney Health Heart Disease Treatment Autoimmune Disorders Treatment Frequency Impact of IPF Support for Alzheimer's Patients Idiopathic Pulmonary Fibrosis Multiple Sclerosis Elderly Care Survival Rates Chronic Venous Insufficiency Healthcare Efficiency Innovative Therapies Celiac Disease Celiac Disease Management Huntington's Disease Care Healthcare Models Therapeutic Approaches Vegetative State Treatment-Resistant Epilepsy Therapeutic Innovations Exercise Benefits Neurodegenerative Diseases Fibromyalgia Myasthenia Gravis Lifestyle Adjustments Independence in Illness Neurodegenerative Disorders Cystic Fibrosis Personalized Medicine Huntington's Disease Lupus Care Healthcare Challenges Patient Experiences Weight Management Treatment Innovations Support Services ALS Patient Outcomes Supportive Care Cystic Fibrosis Treatment Diabetes Treatment Dietary Treatment Lupus Nephritis Treatment SMA Treatment Options Patient Compliance Rheumatoid Arthritis Communication Disorders Impact of Fibrosis Sleep Apnea Antiretroviral Therapy Wound Care Symptom Management Family Involvement HIV Treatment Adherence Disability Prevention Respiratory Diseases Living with Parkinson's Disease HIV Treatment Kidney Disease ME/CFS Neurological Care

FDA Expands Approval of J&J’s Imaavy to Treat Warm Autoimmune Hemolytic Anemia

Patients now have the first U.S. treatment for symptomatic wAIHA through Johnson & Johnson’s FcRn‑blocking antibody Imaavy.

Study Links Right-Ventricle Failure and Mitochondrial Changes to Poor Outcomes in PH-HFpEF

Zymeworks to Buy Theravance for $929 Million

Defective 5′‑Leader HIV Genomes Drive Most Persistent Viremia on ART

CAR-T Therapy Puts Three Autoimmune Diseases Into Sustained Remission in One Patient

Single CAR-T Infusion Puts Three Severe Autoimmune Diseases in Remission

Decoy Molecule Blocks Alpha‑Synuclein–ClpP Link, Reversing Mitochondrial Defects in Parkinson’s Models

Monthly Fasting-Mimicking Diet Shows Benefit in Mild Crohn’s, Randomized Trial Finds

Ianalumab Plus Eltrombopag Extends Disease Control in Phase 3 ITP Study Published in NEJM

FDA Approves Novartis’ Itvisma for SMA Patients Ages 2 and Up

Polymer Lets Insulin Cross Skin in Animals, Matching Injections in Early Tests

Study Reports Blood Test That Detects ME/CFS With 96% Accuracy

Gene Therapy Slows Huntington’s Progression by 75% in Early Trial, uniQure Says

Biogen to Buy Alcyone for $85 Million, Gaining Rights to ThecaFlex DRx

2025 Lasker-DeBakey Award Honors Scientists Behind Trikafta’s Cystic Fibrosis Breakthrough

Soft Wireless Implant Shows Precise Drug Delivery to Deep Brain Regions

Subcutaneous EEG Implant Outperforms Self-Reporting in Long-Term Seizure Monitoring

Adaptive Cycling Alters Brain Activity in Parkinson’s Patients, Study Finds

Ambroxol Demonstrates Safety and Neuroprotection Signals in Parkinson’s Dementia Trial